The DOI matches its Crossref record; 82 of the 82 references it cites were found in a registry or an index.
Cardiac and Metabolic Effects of Anabolic-Androgenic Steroid Abuse on Lipids, Blood Pressure, Left Ventricular Dimensions, and Rhythm
Open accessAbstract
Recent surveys and reports suggest that many athletes and bodybuilders abuse anabolic-androgenic steroids (AAS). However, scientific data on the cardiac and metabolic complications of AAS abuse are divergent and often conflicting. A total of 49 studies describing 1,467 athletes were reviewed to investigate the cardiovascular effects of the abuse of AAS. Although studies were typically small and retrospective, some associated AAS abuse with unfavorable effects. Otherwise healthy young athletes abusing AAS may show elevated levels of low-density lipoprotein and low levels of high-density lipoprotein. Although data are conflicting, AAS have also been linked with elevated systolic and diastolic blood pressure and with left ventricular hypertrophy that may persist after AAS cessation. Finally, in small case studies, AAS abuse has been linked with acute myocardial infarction and fatal ventricular arrhythmias. In conclusion, recognition of these adverse effects may improve the education of athletes and increase vigilance when evaluating young athletes with cardiovascular abnormalities.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
THE MITOCHONDRIAL DEATH/LIFE REGULATOR IN APOPTOSIS AND NECROSIS
Kroemer, G., Dallaporta, B., & Resche-Rigon, M. (1998) · Annual Review of Physiology · doi:10.1146/annurev.physiol.60.1.619 · Cited by 1,963
Sudden death in young athletes.
Maron, B. J., Roberts, W. C., McAllister, H. A., Rosing, D. R., & Epstein, S. E. (1980) · Circulation · doi:10.1161/01.cir.62.2.218 · Cited by 836
Androgens and Cardiovascular Disease
Liu, P. Y., Death, A. K., & Handelsman, D. J. (2003) · Endocrine Reviews · doi:10.1210/er.2003-0005 · Cited by 695
Pope, H. G. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950050035004 · Cited by 604
Androgen Receptors Mediate Hypertrophy in Cardiac Myocytes
Marsh, J. D., Lehmann, M. H., Ritchie, R. H., Gwathmey, J. K., Green, G. E., & Schiebinger, R. J. (1998) · Circulation · doi:10.1161/01.cir.98.3.256 · Cited by 432
Anabolic Androgenic Steroids: A Survey of 500 Users
PARKINSON, A. B., & EVANS, N. A. (2006) · Medicine & Science in Sports & Exercise · doi:10.1249/01.mss.0000210194.56834.5d · Cited by 428
The cardiac toxicity of anabolic steroids
Sullivan, M. L., Martinez, C. M., Gennis, P., & Gallagher, E. J. (1998) · Progress in Cardiovascular Diseases · doi:10.1016/s0033-0620(98)80019-4 · Cited by 342
Anabolic-Androgenic Steroid Use in the United States
Yesalis, C. E. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03510100067034 · Cited by 331
Adverse effects of anabolic steroids in athletes
Maravelias, C., Dona, A., Stefanidou, M., & Spiliopoulou, C. (2005) · Toxicology Letters · doi:10.1016/j.toxlet.2005.06.005 · Cited by 314
Lieberherr, M., & Grosse, B. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37270-8 · Cited by 275
Are the cardiac effects of anabolic steroid abuse in strength athletes reversible?
Urhausen, A., Albers, T., & Kindermann, W. (2004) · Heart · doi:10.1136/hrt.2003.015719 · Cited by 275
Contrasting Effects of Testosterone and Stanozolol on Serum Lipoprotein Levels
Thompson, P. D. (1989) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1989.03420080085036 · Cited by 274
Anabolic-Androgenic Steroid Therapy in the Treatment of Chronic Diseases
Basaria, S., Wahlstrom, J. T., & Dobs, A. S. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.11.7983 · Cited by 234
Atherogenic Effects of Anabolic Steroids on Serum Lipid Levels: A Literature Review
Glazer, G. (1991) · Archives of Internal Medicine · doi:10.1001/archinte.1991.00400100013003 · Cited by 234
Behavioral and physiological responses to anabolic-androgenic steroids
Clark, A. S., & Henderson, L. P. (2003) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(03)00064-2 · Cited by 231
Anabolic-Androgenic Steroid Therapy in the Treatment of Chronic Diseases
Basaria, S. S. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.11.5108 · Cited by 223
Effects of androgenic-anabolic steroids on apolipoproteins and lipoprotein (a)
Hartgens, F., Rietjens, G., Keizer, H. A., Kuipers, H., & Wolffenbuttel, B. H. R. (2004) · British Journal of Sports Medicine · doi:10.1136/bjsm.2003.000199 · Cited by 213
Increased Premature Mortality of Competitive Powerlifters Suspected to Have Used Anabolic Agents
Pärssinen, M., Kujala, U., Vartiainen, E., Sarna, S., & Seppälä, T. (2000) · International Journal of Sports Medicine · doi:10.1055/s-2000-304 · Cited by 199
Atherogenic effects of anabolic steroids on serum lipid levels. A literature review
Glazer, G. (1991) · Archives of Internal Medicine · doi:10.1001/archinte.151.10.1925 · Cited by 194
Acute myocardial infarction in a 22-year-old world class weight lifter using anabolic steroids
McNutt, R. A., Ferenchick, G. S., Kirlin, P. C., & Hamlin, N. J. (1988) · The American Journal of Cardiology · doi:10.1016/0002-9149(88)91390-2 · Cited by 187
Anabolic Steroids: A Review for the Clinician
Kutscher, E. C., Lund, B. C., & Perry, P. J. (2002) · Sports Medicine · doi:10.2165/00007256-200232050-00001 · Cited by 187
D’Andrea, A., Caso, P., Salerno, G., Scarafile, R., De Corato, G., Mita, C., Di Salvo, G., Severino, S., Cuomo, S., Liccardo, B., et al. (2007) · British Journal of Sports Medicine · doi:10.1136/bjsm.2006.030171 · Cited by 183
Serious cardiovascular side effects of large doses of anabolic steroids in weight lifters
Nieminen, M. S., Ramo, M. P., Viitasalo, M., Heikkila, P., Karjalainen, J., Mantysaari, M., & Heikkila, J. (1996) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a014724 · Cited by 178
Human growth hormone doping in sport
Saugy, M., Robinson, N., Saudan, C., Baume, N., Avois, L., & Mangin, P. (2006) · British Journal of Sports Medicine · doi:10.1136/bjsm.2006.027573 · Cited by 175
Steroid Use and Long-Term Health Risks in Former Athletes
Pärssinen, M., & Seppala, T. (2002) · Sports Medicine · doi:10.2165/00007256-200232020-00001 · Cited by 171
Kuhn, C. M. (2002) · Recent Progress in Hormone Research · doi:10.1210/rp.57.1.411 · Cited by 168
The History of Synthetic Testosterone
Hoberman, J. M., & Yesalis, C. E. (1995) · Scientific American · doi:10.1038/scientificamerican0295-76 · Cited by 167
Anabolic steroid abuse and cardiac death
Kennedy, M. C., & Lawrence, C. (1993) · Medical Journal of Australia · doi:10.5694/j.1326-5377.1993.tb121797.x · Cited by 162
Fineschi, V., Riezzo, I., Centini, F., Silingardi, E., Licata, M., Beduschi, G., & Karch, S. B. (2006) · International Journal of Legal Medicine · doi:10.1007/s00414-005-0055-9 · Cited by 161
Mottram, D. R., & George, A. J. (2000) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1053/beem.2000.0053 · Cited by 160
Cause and Manner of Death Among Users of Anabolic Androgenic Steroids
Thiblin, I., Lindquist, O., & Rajs, J. (2000) · Journal of Forensic Sciences · doi:10.1520/jfs14635j · Cited by 156
Androgenic anabolic steroids and arterial structure and function in male bodybuilders
Sader, M. A., Griffiths, K. A., McCredie, R. J., Handelsman, D. J., & Celermajer, D. S. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)01083-4 · Cited by 145
Current perspectives on anabolic-androgenic steroid abuse
Lukas, S. E. (1993) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(93)90032-f · Cited by 144
Kuipers, H., Wijnen, J. A. G., Hartgens, F., & Willems, S. (1991) · International Journal of Sports Medicine · doi:10.1055/s-2007-1024704 · Cited by 142
Physiologie hypertrophy: Effects on left ventricular systolic mechanics in athletes
Colan, S. D., Sanders, S. P., & Borow, K. M. (1987) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(87)80232-2 · Cited by 138
D’Andrea, A., Limongelli, G., Caso, P., Sarubbi, B., Pietra, A. D., Brancaccio, P., Cice, G., Scherillo, M., Limongelli, F. M., & Calabrò, R. (2002) · International Journal of Cardiology · doi:10.1016/s0167-5273(02)00194-8 · Cited by 132
De Piccoli, B., Giada*, F., Benettin, A., Sartori*, F., & Piccolo, E. (1991) · International Journal of Sports Medicine · doi:10.1055/s-2007-1024703 · Cited by 132
Luke, J. L., Farb, A. A., Virmani, R., & Sample, R. H. B. (1990) · Journal of Forensic Sciences · doi:10.1520/jfs12981j · Cited by 130
Sudden Cardiac Death in a 20-Year-Old Bodybuilder Using Anabolic Steroids
Dickerman, R. D., Schaller, F. A., Prather, I. D., & McConathy, W. J. (2008) · Cardiology · doi:10.1159/000176867 · Cited by 128
Lenders, J., Demacker, P., Vos, J., Jansen, P., Hoitsma, A., van 't Laar, A., & Thien, T. (1988) · International Journal of Sports Medicine · doi:10.1055/s-2007-1024972 · Cited by 126
Sharma, S. (2003) · Experimental Physiology · doi:10.1113/eph8802624 · Cited by 125
Cardiac effects of anabolic steroids
Payne, J. R., Kotwinski, P. J., & Montgomery, H. (2004) · Heart · doi:10.1136/hrt.2003.025783 · Cited by 119
Hausmann, R., Hammer, S., & Betz, P. (1998) · International Journal of Legal Medicine · doi:10.1007/s004140050165 · Cited by 117
One- and two-dimensional echocardiography in bodybuilders using anabolic steroids
Urhausen, A. J. P., H�lpes, R., & Kindermann, W. (1989) · European Journal of Applied Physiology · doi:10.1007/bf00418510 · Cited by 116
Nottin, S., Nguyen, L.-D., Terbah, M., & Obert, P. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.10.026 · Cited by 116
Karila, T. A., Karjalainen, J., Mäntysaari, M., Viitasalo, M. T., & Seppälä, T. A. (2003) · International Journal of Sports Medicine · doi:10.1055/s-2003-40702 · Cited by 111
Henkin, Y. (1992) · JAMA · doi:10.1001/jama.1992.03480070077035 · Cited by 102
Ferenchick, G. S., & Adelman, S. (1992) · American Heart Journal · doi:10.1016/0002-8703(92)90620-b · Cited by 96
Kai, H., Muraishi, A., Sugiu, Y., Nishi, H., Seki, Y., Kuwahara, F., Kimura, A., Kato, H., & Imaizumi, T. (1998) · Circulation Research · doi:10.1161/01.res.83.6.594 · Cited by 94
Jenkins, P. J. (1999) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1999.00784.x · Cited by 91
Urhausen, A. J. P., Albers, T., & Wilfried, K. (2003) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(03)00105-5 · Cited by 90
Anabolic/androgenic steroid abuse and thrombosis: Is there a connection?
Ferenchick, G. S. (1991) · Medical Hypotheses · doi:10.1016/0306-9877(91)90079-e · Cited by 86
The Incidence of Anabolic Steroid Use among Competitive Bodybuilders
Tricker, R., O'Neill, M. R., & Cook, D. (1989) · Journal of Drug Education · doi:10.2190/egt5-4ywd-qx15-flkk · Cited by 81
Impaired vasoreactivity in bodybuilders using androgenic anabolic steroids
Lane, H. A., Grace, F., Smith, J. C., Morris, K., Cockcroft, J., Scanlon, M. F., & Davies, J. S. (2006) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2006.01667.x · Cited by 80
Cardiovascular Effects of Anabolic Steroids in Weight‐Trained Subjects
Palatini, P., Giada, F., Garavelli, G., Sinisi, F., Mario, L., Michieletto, M., & Baldo-Enzi, G. (1996) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1996.tb04167.x · Cited by 76
Left Ventricular Size and Function in Elite Bodybuilders Using Anabolic Steroids
Dickerman, R. D., Schaller, F. A., Zachariah, N. Y., & McConathy, W. J. (1997) · Clinical Journal of Sport Medicine · doi:10.1097/00042752-199704000-00003 · Cited by 75
The effects of anabolic steroids on myocardial structure and cardiovascular fitness
Sachtleben, T. R., Berg, K. E., Elias, B., Cheatham, J. P., Felix, G. L., & Hofschire, P. J. (1993) · Medicine & Science in Sports & Exercise · doi:10.1249/00005768-199311000-00006 · Cited by 74
An acute myocardial infarction occurring in an anabolic steroid user
Huie, M. J. (1994) · Medicine & Science in Sports & Exercise · doi:10.1249/00005768-199404000-00002 · Cited by 73
Hartgens, F., Cheriex, E. C., & Kuipers, H. (2003) · International Journal of Sports Medicine · doi:10.1055/s-2003-40705 · Cited by 71
Illicit drugs and cardiac arrhythmias in athletes
Furlanello, F., Serdoz, L. V., Cappato, R., & De Ambroggi, L. (2007) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/hjr.0b013e3280ecfe3e · Cited by 70
Effects of testosterone and nandrolone on cardiac function: a randomized, placebo‐controlled study
Chung, T., Kelleher, S., Liu, P. Y., Conway, A. J., Kritharides, L., & Handelsman, D. J. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02715.x · Cited by 61
Endocrine effects in female weight lifters who self-administer testosterone and anabolic steroids
Malarkey, W. B., Strauss, R. H., Leizman, D. J., Liggett, M., & Demers, L. M. (1991) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(91)90374-z · Cited by 61
Bello, V. D., Giorgi, D., Bianchi, M., BERTINI, A., Caputo, M. T., VALENTI, G., FURIOSO, O., Alessandri, L., Paterni, M., & Giusti, C. (1999) · Medicine & Science in Sports & Exercise · doi:10.1097/00005768-199904000-00004 · Cited by 60
MYOCARDIAL INFARCTION WITH EXTENSIVE INTRACORONARY THROMBUS INDUCED BY ANABOLIC STEROIDS
Fisher, M., Appleby, M., Rittoo, D., & Cotter, L. (1996) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.1996.tb09532.x · Cited by 57
Testosterone and coronary vascular tone: Implications in coronary artery disease
Wynne, F. L., & Khalil, R. A. (2003) · Journal of Endocrinological Investigation · doi:10.1007/bf03345150 · Cited by 55
Anabolic steroids and infarction.
Bowman, S. (1990) · BMJ · doi:10.1136/bmj.300.6726.750-c · Cited by 53
Petersson, A. M., Garle, M., Granath, F. N., & Thiblin, I. (2005) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2005.07.001 · Cited by 52
Baldo-Enzi, G., Giada, F., Zuliani, G., Baroni, L., Vitale, E., Enzi, G., Magnanini, P., & Fellin, R. (1990) · Metabolism · doi:10.1016/0026-0495(90)90076-o · Cited by 51
Effects of androgens on the cardiovascular system.
Rosano, G. M. C., Cornoldi, A., & Fini, M. (2005) · PubMed · Cited by 51
The blood pressure response to exercise in anabolic steroid users.
Riebe, D. A., Fernhall, B., & Thompson, P. D. (1992) · PubMed · Cited by 47
YEATER, R. A., Reed, C., Ullrich, I. H., et al. (1996) · British Journal of Sports Medicine · doi:10.1136/bjsm.30.1.11 · Cited by 46
Bagchus, W. M., Smeets, J. M. W., Verheul, H. A. M., Veen, S. M. D. J.-V. D., Port, A., & Geurts, T. B. P. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1526 · Cited by 45
The blood pressure response to exercise in anabolic steroid users
Riebe, D. A., Fernhall, B., & Thompson, P. D. (1992) · Medicine & Science in Sports & Exercise · doi:10.1249/00005768-199206000-00004 · Cited by 45
Sports Illustrated,the Mainstream Press and the Enactment of Drug Policy in Major League Baseball
Denham, B. E. (2004) · Journalism · doi:10.1177/1464884904039554 · Cited by 44
Ferrer, M., Encabo, A., Marı́n, J., & Balfagón, G. (1994) · European Journal of Pharmacology · doi:10.1016/0014-2999(94)90602-5 · Cited by 41
Noninvasive evaluation of world class athletes engaged in different modes of training
Fisher, A., Adams, T. D., Yanowitz, F. G., Ridges, J. D., Orsmond, G. S., & Nelson, A. G. (1989) · The American Journal of Cardiology · doi:10.1016/0002-9149(89)90342-1 · Cited by 41
Curry, L. A., & Wagman, D. F. (1999) · Perceptual and Motor Skills · doi:10.2466/pms.1999.88.1.224 · Cited by 40
Lipid profile of body builders with and without self-administration of anabolic steroids
Fröhlich, J., Kullmer, T., Urhausen, A. J. P., Bergmann, R., & Kindermann, W. (1989) · European Journal of Applied Physiology · doi:10.1007/bf02396586 · Cited by 32
Hislop, M., Gibson, A. S. C., Lambert, M., Noakes, T. D., & Marais, A. D. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(01)00519-6 · Cited by 31
Anabolic Steroids: A Fatal Attraction?
Wood, R. I. (2006) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2006.01407.x · Cited by 28
Lipoprotein analysis in bodybuilders
McKillop, G., & Ballantyne, D. (1987) · International Journal of Cardiology · doi:10.1016/0167-5273(87)90077-5 · Cited by 24
Evolution of serum lipids in two male bodybuilders using anabolic steroids
Lajarin, F., Zaragoza, R., Tovar, I., & Martinez-Hernandez, P. (1996) · Clinical Chemistry · doi:10.1093/clinchem/42.6.970 · Cited by 8
Cited by
Pope, H. G., Wood, R. I., Rogol, A., Nyberg, F., Bowers, L., & Bhasin, S. (2014) · Endocrine Reviews · doi:10.1210/er.2013-1058 · Cited by 658
Adverse Effects of Anabolic-Androgenic Steroids: A Literature Review
Albano, G. D., Amico, F., Cocimano, G., Liberto, A., Maglietta, F., Esposito, M., Rosi, G. L., Di Nunno, N., Salerno, M., & Montana, A. (2021) · Healthcare · doi:10.3390/healthcare9010097 · Cited by 200
“AAS use in supraphysiological doses is associated with abnormal plasma lipoproteins [59,66,67].”
BackgroundSudden Cardiac Death in Young Athletes
Finocchiaro, G., Westaby, J., Sheppard, M. N., Papadakis, M., & Sharma, S. (2024) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2023.10.032 · Cited by 115
Doping in sport: effects, harm and misconceptions
Birzniece, V. (2015) · Internal Medicine Journal · doi:10.1111/imj.12629 · Cited by 99
McCullough, D., Webb, R., Enright, K. J., Lane, K. E., McVeigh, J., Stewart, C. E., & Davies, I. G. (2021) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-020-09616-y · Cited by 62
“Hypertension, as a result of chronic AAS use, is under debate due to conflicting data [33].”
BackgroundInfluential
Metadata
- Authors
- Achar, S., Rostamian, A., & Narayan, S. M.
- Venue
- The American Journal of Cardiology
- Publisher
- Elsevier BV
- Published
- 2010-09
- Volume
- 106
- Issue
- 6
- Pages
- 893-901
- ISSN
- 0002-9149 (ISSN-L)
- OpenAlex
- W2069026977
- Cited by
- 265
- References
- 82
- FWCI
- 8.81
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.